Target intelligence / Profile preview

Cytokine receptor common beta subunit (CSF2RB)

Target
CSF2RB
Molecular classification
Receptor, Type I cytokine receptor, Signal transduction subunit, Component of the IL-3/IL-5/GM-CSF receptor family
01

Overview

The **cytokine receptor common beta subunit (CSF2RB, also known as the common beta chain or βc)** is a transmembrane protein that functions as the signal-transducing subunit shared by the receptors for interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF)[2][3][4]. While the α subunits of these receptors confer ligand specificity, the β subunit is required for high-affinity ligand binding and intracellular signaling activation, especially involving JAK/STAT pathways[2][3]. The βc subunit is broadly expressed in hematopoietic cells and plays a critical role in eosinophil biology and the immune response, especially in conditions such as asthma and allergic inflammation[2][4]. Targeting this subunit or its associated signaling pathways is of significant therapeutic interest in the management of eosinophil-driven diseases.

Other names
Common beta chainβcCD131Beta chain of interleukin-5 receptorCytokine receptor common subunit betaIL5RB
02

Mechanism of action

Monoclonal antibodies prevent IL-5 from binding its receptor or deplete IL-5 receptor-expressing cells, thereby inhibiting downstream βc-mediated signaling and reducing eosinophil survival and activation[3]

03

Biological functions

Signal transductionImmune responseHematopoiesis (regulation of blood cell development)Eosinophil activationCell proliferation
04

Disease associations

InflammationCancerAsthmaAllergic diseasesAutoimmune diseases
05

Safety considerations

Increased risk of infections (due to suppression of immune effector cells)Potential for hypersensitivity reactions (due to monoclonal antibody therapy)Long-term suppression of eosinophils may impact host defense
06

Interacting drugs

Benralizumab (targets IL-5Rα, but blocks signaling through the β subunit)[3]

2 more in the full profile.

07

Biomarkers

CSF2RB expression on leukocytesEosinophil count (used indirectly to monitor effects of IL-5 pathway modulation)

Beyond the preview

Go deeper on Cytokine receptor common beta subunit (CSF2RB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine receptor common beta subunit (CSF2RB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call